DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia
2021 · Scientific Reports · 32 citations
https://doi.org/10.1038/s41598-021-90500-3
R
Rafael Heinz Montoya
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
88
Citations
5
h-index
2
i10-index
Rafael Heinz Montoya is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Cancer-related Molecular Pathways & Cancer, Hypoxia, and Metabolism. The author has an h-index of 5, co-authored 20 publications.
ORCID: 0000-0003-2335-5894Papers by this author
worksAge-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice
2024 · Cell Reports Medicine · 5 citations
https://doi.org/10.1016/j.xcrm.2024.101558
Mdm2/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage
2023 · Cell Death and Disease · 4 citations
https://doi.org/10.1038/s41419-023-05844-7
Mdm2/p53 levels in bone marrow mesenchymal stromal cells is essential for maintaining the hematopoietic niche in response to DNA damage
2023 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-2544760/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat